Prostate Cancer and Prostatic Diseases This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

The role of preoperative prostatic shape in the recovery of urinary continence after robotic radical prostatectomy: a single cohort analysis
Prostate Cancer and Prostatic Diseases, Published online: 21 June 2022; doi:10.1038/s41391-022-00563-0The role of preoperative prostatic shape in the recovery of urinary continence after robotic radical prostatectomy: a single cohort analysis (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - June 21, 2022 Category: Urology & Nephrology Authors: V. Iacovelli M. Carilli M. Sandri V. Forte C. Cipriani R. Bertolo M. Vittori F. Petta F. Maiorino M. Signoretti M. Antonucci A. U. Cavallo M. Sperandio E. Finazzi Agr ò P. Bove Source Type: research

Pharmacotherapy vs. minimally invasive therapies as initial therapy for moderate-to-severe benign prostatic hyperplasia: a cost-effectiveness study
Prostate Cancer and Prostatic Diseases, Published online: 10 June 2022; doi:10.1038/s41391-022-00561-2Pharmacotherapy vs. minimally invasive therapies as initial therapy for moderate-to-severe benign prostatic hyperplasia: a cost-effectiveness study (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - June 10, 2022 Category: Urology & Nephrology Authors: Yeva Sahakyan Aysegul Erman Naeem Bhojani Bilal Chughtai Kevin C. Zorn Beate Sander Dean S. Elterman Source Type: research

Validation of the prostate cancer comorbidity index in predicting cause-specific mortality in men undergoing radical prostatectomy
Prostate Cancer and Prostatic Diseases, Published online: 06 June 2022; doi:10.1038/s41391-022-00550-5Validation of the prostate cancer comorbidity index in predicting cause-specific mortality in men undergoing radical prostatectomy (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - June 6, 2022 Category: Urology & Nephrology Authors: Michelle S. Chen Lauren E. Howard Shannon Stock Anna Dolgner Stephen J. Freedland William Aronson Martha Terris Zachary Klaassen Christopher Kane Christopher Amling Matthew Cooperberg Timothy J. Daskivich Source Type: research

Cardiovascular risk of gonadotropin-releasing hormone antagonist versus agonist in men with prostate cancer: an observational study in Taiwan
Prostate Cancer and Prostatic Diseases, Published online: 03 June 2022; doi:10.1038/s41391-022-00555-0Cardiovascular risk of gonadotropin-releasing hormone antagonist versus agonist in men with prostate cancer: an observational study in Taiwan (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - June 3, 2022 Category: Urology & Nephrology Authors: Shao Yu-Hsuan Joni Hong Jian-Hua Chen Chun-Kai Huang Chao-Yuan Source Type: research

The EXPANDER-1 trial: introduction of the novel Urocross™ Expander System for treatment of lower urinary tract symptoms (LUTS) secondary to benign prostatic hyperplasia (BPH)
Prostate Cancer and Prostatic Diseases, Published online: 31 May 2022; doi:10.1038/s41391-022-00548-zThe EXPANDER-1 trial: introduction of the novel Urocross™ Expander System for treatment of lower urinary tract symptoms (LUTS) secondary to benign prostatic hyperplasia (BPH) (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - May 31, 2022 Category: Urology & Nephrology Authors: Henry H. Woo Chi-Ping Huang William J. Huang Yi-Huei Chang Chi-Shun Lien Archil Chkhotua Dean S. Elterman Source Type: research